Ductal carcinoma in situ

Disease4 papers1 finding

Humans2
In silico2

Associations

1

Lobular carcinoma in situ

upin humans1

1 study

Lobular carcinoma in situ raises the risk of ductal carcinoma in situ in humans (8.82-fold (95% CI: 5.39-14.4)).
Humans
Advancing Evidence of the Associations between specific Benign Breast Diagnoses and Future Breast Cancer Risk · Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 18 Aug 2026

Lobular carcinoma in situ →

Trial sponsors

Xoft
Company1 trialPhase 463 people
QuantumLeap Healthcare Collaborative
1 trialPhase 2400 people
Institut Cancerologie de l'Ouest
1 trialPhase 2262 people
European Institute of Oncology
1 trialPhase 2110 people
Julie Nangia
1 trialPhase 284 people
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
1 trialPhase 263 people
University of Chicago
1 trialPhase 220 people
Finn, Olivera, PhD
1 trialPhase 150 people

Latest

4

CancersIn silico15 Sep

Age Limits of Breast Cancer Screening with Mammography-A Decision-Analytic Benefit-Harm Evaluation to Inform DecisionMaking for the German Context

Journal of the National Cancer InstituteIn silico13 Sep

Breast cancer overdiagnosis in mammography trials-separating signal from noise: a meta-analysis

Environmental PollutionHumans21 Aug

Water arsenic levels and breast cancer risk in a United States-wide prospective cohort

Cancer Epidemiology, Biomarkers & PreventionHumans18 Aug

Advancing Evidence of the Associations between specific Benign Breast Diagnoses and Future Breast Cancer Risk